Intrachromosomal rearrangements fusing L-myc and rlf in small-cell lung cancer.

AUTOR(ES)

Mäkelä, T P

RESUMO

Chromosomal abnormalities affecting proto-oncogenes are frequently detected in human cancer. Oncogenes of the myc family are activated in several types of tumors as a result of gene amplification or chromosomal translocation. We have recently found the L-myc gene involved in a gene fusion in small-cell lung cancer (SCLC). This results in a chimeric protein with amino-terminal sequences from a novel gene named rif joined to L-myc. Here we present a preliminary structural characterization of the rlf-L-myc fusion gene, which has been found only in cells with an amplified L-myc gene. In addition, we have used somatic cell hybrids to assign the normal rlf locus to the same chromosome (chromosome 1) on which L-myc resides. Finally, we have been able to establish a physical linkage between rif and L-myc with pulsed-field gel electrophoresis. Our results demonstrate that normal rlf and L-myc genes are separated by less than 800 kb of DNA. Thus, the rlf-L-myc gene fusions are due to similar but not identical intrachromosomal rearrangements at 1p32. The presence of independent genetic lesions that cause the formation of identical chimeric rlf-L-myc proteins suggests a role for the fusion protein in the development of these tumors.

Documentos Relacionados

• Complex intrachromosomal rearrangement in the process of amplification of the L-myc gene in small-cell lung cancer.
• Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer.
• Treatment of Small-Cell Lung Cancer
• A unique cell-surface protein phenotype distinguishes human small-cell from non-small-cell lung cancer.
• Cholera toxin inhibits signal transduction by several mitogens and the in vitro growth of human small-cell lung cancer.